Pavmed Inc C/Wts 30/04/2024(To Pur Com) Class Z News

PAVmed Positioned for Growth Despite Q3 Revenue Miss: Buy Rating Affirmed by Anthony Vendetti

TipRanksNov 16 20:18

Optimistic Buy Rating for PAVmed Amid Strategic Positioning and Promising Financial Outlook

TipRanksSep 26 03:35

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow JonesSep 10 17:42

PAVmed Analyst Ratings

BenzingaSep 10 17:32

Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $21

BenzingaSep 10 17:32

Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and PAVmed (PAVM)

TipRanksMay 16 20:20

Analysts' Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)

TipRanksMay 16 03:45

PAVmed (PAVM) Receives a Buy From Lake Street

TipRanksMay 15 21:05

Buy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product Commercialization

TipRanksApr 15 17:20

Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target

TipRanksMar 29 19:50

Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)

TipRanksMar 28 21:25

Cantor Fitzgerald Reiterates Neutral on PAVmed, Maintains $1.4 Price Target

BenzingaAug 18, 2023 22:46

PAVmed Analyst Ratings

BenzingaAug 18, 2023 22:45

PAVmed (PAVM) Receives a Buy From Maxim Group

TipRanksAug 18, 2023 19:45

Maxim Group Remains a Buy on PAVmed (PAVM)

TipRanksMay 19, 2023 03:35

Ascendiant Sticks to Its Buy Rating for PAVmed (PAVM)

TipRanksApr 12, 2023 15:10

Cantor Fitzgerald Downgrades PAVmed to Neutral From Overweight, Cuts Price Target to $1.50 From $4

MT NewswiresJan 20, 2023 21:38

PAVmed Analyst Ratings

Benzinga Analyst RatingsJan 20, 2023 20:46

Lake Street Adjusts PAVmed's Price Target to $1.50 From $5, Maintains Buy Rating

MT NewswiresJan 19, 2023 09:58

PAVmed Analyst Ratings

Benzinga Analyst RatingsJan 18, 2023 22:41